Medical Services related to Mark Charles Hannibal MD, PhD
Genetics, Metabolism and Genomic Medicine (Pediatric)
At the Division of Pediatric Genetics, Metabolism and Genomic Medicine at C.S. Mott Children's Hospital, part of the University of Michigan Health System, we provide comprehensive care in the diagnosis, treatment and prevention of birth defects, structural abnormalities, inherited diseases, chromosomal abnormalities and intellectual disabilities.
Hereditary Hemorrhagic Telangiectasia (HHT)
Hereditary Hemorrhagic Telangiectasia (HHT) is a genetic disorder that affects about one in 5,000 people and commonly causes nosebleeds, with more frequent nosebleeds typically starting after about age 12. Patients with HHT have a tendency to form blood vessels that are abnormal, fragile, and bleed more easily. Michigan Medicine has a multidisciplinary team of physicians to treat HHT, including specialists in otolaryngology (for nosebleeds), pulmonary diseases, interventional radiology, gastroenterology, neurosurgery, liver diseases, cardiology, heart failure, dermatology, radiation oncology, hematology-oncology and associated pediatric subspecialties.
Hereditary Hemorrhagic Telangiectasia (HHT) Treatment
There are many different specialists who treat patients with HHT. Many patients will eventually see two or more types of specialists, especially later in adulthood. Specialists who treat HHT include otolaryngologists (ear, nose & throat doctors), interventional radiologists (to treat AVMs), hematologists (to help manage anemia), and more.
Immuno-Hematology
The Immuno-Hematology Clinic at the University of Michigan brings together dedicated physicians, researchers, nurses, and social workers to deliver unsurpassed comprehensive care to children suffering from immune deficiencies, bone marrow failure syndromes, lymphoproliferative diseases and neutrophil disorders.